AVANOS MEDICAL, INC. Quarterly Goodwill in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Avanos Medical, Inc. quarterly Goodwill history and growth rate from Q4 2012 to Q3 2024.
  • Avanos Medical, Inc. Goodwill for the quarter ending September 30, 2024 was $795M, a 0.46% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $795M +$3.6M +0.46% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $794M +$31.8M +4.17% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $795M -$26.6M -3.24% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $796M +$35.8M +4.71% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $792M -$32.1M -3.9% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $763M -$62.4M -7.56% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $822M -$4.5M -0.55% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $760M +$17.8M +2.4% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $824M +$21.8M +2.72% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $825M +$22.4M +2.79% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $826M +$23.9M +2.98% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $743M -$60M -7.48% Dec 31, 2021 10-K 2024-02-21
Q3 2021 $802M +$600K +0.08% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $803M +$2.4M +0.3% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $802M +$2.3M +0.29% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $803M +$1.6M +0.2% Dec 31, 2020 10-K 2023-02-21
Q3 2020 $801M +$700K +0.09% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $800M +$17.9M +2.29% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $800M +$16.1M +2.05% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $801M +$17.3M +2.21% Dec 31, 2019 10-K 2022-02-23
Q3 2019 $801M +$13.8M +1.75% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $782M +$18.5M +2.42% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $784M +$19.1M +2.5% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $784M +$18.9M +2.47% Dec 31, 2018 10-K 2021-02-19
Q3 2018 $787M -$245M -23.8% Sep 30, 2018 10-Q/A 2018-12-17
Q2 2018 $764M -$267M -25.9% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $765M -$265M -25.7% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $765M +$2.4M +0.32% Dec 31, 2017 10-K 2020-02-25
Q3 2017 $1.03B +$100K +0.01% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $1.03B -$700K -0.07% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $1.03B +$82.9M +8.76% Mar 31, 2017 10-Q 2017-05-02
Q4 2016 $762M +$83.9M +12.4% Dec 31, 2016 10-K 2019-02-26
Q3 2016 $1.03B +$88.5M +9.38% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $1.03B -$391M -27.5% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $947M -$475M -33.4% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $678M -$748M -52.4% Dec 31, 2015 10-K 2018-02-27
Q3 2015 $943M -$486M -34% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $1.42B Jun 30, 2015 10-Q 2015-08-12
Q1 2015 $1.42B Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $1.43B -$4M -0.28% Dec 31, 2014 10-K 2017-02-27
Q3 2014 $1.43B Sep 30, 2014 10-Q 2014-11-20
Q4 2013 $1.43B -$4M -0.28% Dec 31, 2013 10-K 2016-02-29
Q4 2012 $1.43B Dec 31, 2012 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.